- ￥269 - 4113
- MedChemExpress(MCE)
- 美国
- HY-102024
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
CPI-444 analog
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
443103-97-7
- 规格：
1 mg/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格： | 1 mg | 产品价格： | ￥269.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥583.0 |
| 规格： | 10 mg | 产品价格： | ￥938.0 |
| 规格： | 25 mg | 产品价格： | ￥1963.0 |
| 规格： | 50 mg | 产品价格： | ￥2888.0 |
| 规格： | 100 mg | 产品价格： | ￥4113.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
A2A receptor antagonist 1
CAS No. : 443103-97-7
MCE 国际站：A2A receptor antagonist 1
产品活性：A2A receptor antagonist 1 (CPI-444 analog) 是 adenosine A2A receptor 和 A1 receptor 的拮抗剂，Ki 值分别为 4 和 264 nM 。
研究领域：GPCR/G Protein
作用靶点：Adenosine Receptor
In Vitro: A2A receptor antagonist 1 (CPI-444 analog) is a potent adenosine A2A receptor antagonist, selective over the A1 receptor and demonstrates its binding activity with Ki values of 4 and 264 nM, respectively.
相关产品：Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Anti-Cancer Compound Library | Small Molecule Immuno-Oncology Compound Library | Neurotransmitter Receptor Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | 5'-N-Ethylcarboxamidoadenosine | Theophylline | ZM241385 | CGS 21680 Hydrochloride | SCH 58261 | Etrumadenant | Istradefylline | Inosine | BAY 60-6583 | DPCPX | Ciforadenant | Imaradenant | Namodenoson | Piclidenoson | Regadenoson | MRS 1754 | PSB-603 | SCH442416 | Adenosine 5'-monophosphate monohydrate | Preladenant | MRS-1191 | Theobromine | MRS-1706 | Inupadenant | Ticlopidine hydrochloride | Acefylline | Aminophylline | Nitrobenzylthioinosine | Derenofylline | GR79236
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Chemokine Receptor Antagonist Development
This chapter describes assays that focus on the characterization of compounds identified in high-�throughput screening campaigns, and the subsequent medicinal chemistry programs. They cover methods to determine potency
Developing a Photoreactive Antagonist
approach for developing small molecules that, upon irradiation with light, may be used to rapidly inactivate targeted proteins expressed on the surfaces of cells. Highlighted is ANQX, a photoreactive AMPA receptor antagonist developed to irreversibly
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
than clopidogrel without an unacceptable increase in hemorrhagic or other side effects. Prasugrel (CS-747; LY-640315), a novel third-generation oral thienopyridine, is a specific, irreversible antagonist of the platelet ADP P2Y12 receptor. Pre-clinical and early
技术资料暂无技术资料 索取技术资料
